Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Equivalence of Fetal Heart Rate Variability and Accelerations in the Interpretation of Non-Stress Tests.

American journal of perinatology·2026
Same author

Use of Atropine, Ondansetron, and Ketorolac in Suspected Amniotic Fluid Embolism.

Obstetrics and gynecology·2025
Same author

Frequency and timing of complications within the first postpartum year in the United States and Canada: a systematic review and meta-analysis.

American journal of obstetrics and gynecology·2025
Same author

An Organ-Specific Approach to the Management of Gestational Hypertension: Evidence versus Tradition.

American journal of perinatology·2024
Same author

The impact of indication for cesarean on blood loss.

American journal of obstetrics and gynecology·2024
Same author

Interleukin-6 receptor antagonists in pregnancy: a reason for cautious optimism.

The Lancet. Rheumatology·2024

Related Experiment Video

Updated: Jun 3, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Magnesium for fetal neuroprotection.

Shane A Reeves1, Ronald S Gibbs, Steven L Clark

  • 1Department of Obstetrics and Gynecology, University of Colorado School of Medicine, 12631 E. 17th Avenue, Aurora, CO 80045, USA. Shane.reeves@ucdenver.edu

American Journal of Obstetrics and Gynecology
|March 8, 2011
PubMed
Summary

Magnesium sulfate given to mothers before early preterm birth can reduce cerebral palsy risk in newborns. This study offers a clear treatment algorithm for clinicians to effectively use magnesium sulfate for neuroprotection.

More Related Videos

Concurrent Collection of Fetal Murine Brain and Serum to Assess Effects of Maternal Diet on Nutrition and Neurodevelopment in Neurofibromatosis Type 1
05:44

Concurrent Collection of Fetal Murine Brain and Serum to Assess Effects of Maternal Diet on Nutrition and Neurodevelopment in Neurofibromatosis Type 1

Published on: May 17, 2024

Experimental Methods for Testing the Effects of Neurotrophic Peptide, ADNF-9, Against Alcohol-induced Apoptosis during Pregnancy in C57BL/6 Mice
09:50

Experimental Methods for Testing the Effects of Neurotrophic Peptide, ADNF-9, Against Alcohol-induced Apoptosis during Pregnancy in C57BL/6 Mice

Published on: April 24, 2013

Related Experiment Videos

Last Updated: Jun 3, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Concurrent Collection of Fetal Murine Brain and Serum to Assess Effects of Maternal Diet on Nutrition and Neurodevelopment in Neurofibromatosis Type 1
05:44

Concurrent Collection of Fetal Murine Brain and Serum to Assess Effects of Maternal Diet on Nutrition and Neurodevelopment in Neurofibromatosis Type 1

Published on: May 17, 2024

Experimental Methods for Testing the Effects of Neurotrophic Peptide, ADNF-9, Against Alcohol-induced Apoptosis during Pregnancy in C57BL/6 Mice
09:50

Experimental Methods for Testing the Effects of Neurotrophic Peptide, ADNF-9, Against Alcohol-induced Apoptosis during Pregnancy in C57BL/6 Mice

Published on: April 24, 2013

Area of Science:

  • Obstetrics and Gynecology
  • Neonatal Neurology
  • Perinatal Medicine

Background:

  • Evidence suggests magnesium sulfate reduces cerebral palsy risk in preterm neonates.
  • Professional guidelines recommend adhering to randomized trial protocols for its use.
  • Clinical application is challenging due to methodological heterogeneity in trials.

Purpose of the Study:

  • To present a practical approach for magnesium sulfate administration in early preterm delivery.
  • To define patient eligibility criteria for magnesium sulfate therapy.
  • To outline a treatment algorithm, including retreatment and tocolysis.

Main Methods:

  • Review of existing evidence on magnesium sulfate for neuroprotection.
  • Development of a patient selection protocol.
  • Creation of a treatment algorithm for clinical guidance.

Main Results:

  • Identification of specific criteria for qualifying patients.
  • A structured algorithm for magnesium sulfate administration.
  • Considerations for retreatment and concurrent tocolytic therapy.

Conclusions:

  • A defined protocol can facilitate the appropriate use of magnesium sulfate for neonatal neuroprotection.
  • This approach aims to standardize care and improve outcomes for preterm infants.
  • Effective implementation requires clear patient selection and treatment guidelines.